Onpharma Inc

Biobotanical Resource Inc, located in Watsonville, CA, is a company that specializes in providing natural solutions for various health concerns. Their wide range of products includes Biocidin Liquid, Biocidin Capsules, G.I. Detox, Proflora 4R, and many more, each designed to address specific functional activities in the body. Whether it's removing unwanted organisms, eliminating toxins, restoring balance and healing, optimizing resilience, or promoting oral health, Biobotanical Resource Inc offers botanical-based solutions that are simple, effective, and backed by scientific research. With a focus on simplicity and natural solutions, Biobotanical Resource Inc understands the importance of addressing today's complex health needs. Their products are designed to work synergistically with the body, supporting its innate restorative abilities and promoting overall well-being. Whether you're looking for a deep cleanse, immune support, or oral care, Biobotanical Resource Inc provides botanicals that are tailored to meet the diverse needs of individuals seeking natural alternatives for their health concerns.Generated from the website

Global Source is a leading distributor specializing in travel health, comfort, and accessories, offering a wide range of products to enhance your travel experience. With expert consulting services and wholesale options available, Global Source is your go-to destination for all your travel accessory needs. Whether you're looking for travel essentials or seeking professional guidance, Global Source provides top-quality products and personalized consultations to ensure you have a seamless and enjoyable journey. Trust Global Source to equip you with the tools and resources you need for a successful and comfortable travel experience. Generated from their website's infomation

Aridis Pharmaceuticals, Inc. is a late-stage clinical development biopharmaceutical company based in Los Gatos, CA, specializing in transforming first-in-class anti-infectives aimed at addressing life-threatening viral and bacterial respiratory infections. The company leverages proprietary technology platforms to discover rare and potent human monoclonal antibodies, targeting significant infectious diseases such as Hospital Acquired Infections and COVID-19. With a robust pipeline that includes novel antibacterial and antiviral candidates, Aridis is committed to combating public health threats like antimicrobial resistance and viral pandemics. The team, with a proven track record in innovative drug development, focuses on delivering differentiated therapies that rely on unique mechanisms distinct from traditional antibiotics and antivirals. Generated from the website